EMPAGLIFLOZIN for Disease risk factor: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 11 adverse event reports in the FDA FAERS database where EMPAGLIFLOZIN was used for Disease risk factor.
Most Reported Side Effects for EMPAGLIFLOZIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Diabetic ketoacidosis | 3,644 | 9.8% | 85 | 2,610 |
| Fungal infection | 1,941 | 5.2% | 7 | 94 |
| Blood glucose increased | 1,797 | 4.9% | 4 | 306 |
| Euglycaemic diabetic ketoacidosis | 1,769 | 4.8% | 59 | 1,340 |
| Weight decreased | 1,661 | 4.5% | 25 | 328 |
| Urinary tract infection | 1,439 | 3.9% | 42 | 687 |
| Ketoacidosis | 1,411 | 3.8% | 57 | 969 |
| Dizziness | 1,372 | 3.7% | 13 | 274 |
| Nausea | 1,333 | 3.6% | 20 | 594 |
| Vomiting | 1,201 | 3.2% | 49 | 769 |
| Acute kidney injury | 1,023 | 2.8% | 72 | 751 |
| Fournier's gangrene | 1,000 | 2.7% | 63 | 681 |
| Diarrhoea | 999 | 2.7% | 19 | 314 |
| Dehydration | 973 | 2.6% | 24 | 581 |
| Pollakiuria | 944 | 2.6% | 6 | 90 |
Other Indications for EMPAGLIFLOZIN
Product used for unknown indication (16,449)
Type 2 diabetes mellitus (12,176)
Diabetes mellitus (4,267)
Cardiac failure (1,338)
Type 1 diabetes mellitus (383)
Chronic kidney disease (209)
Cardiac failure chronic (172)
Cardiac failure congestive (158)
Cardiac disorder (157)
Blood glucose increased (138)
Other Drugs Used for Disease risk factor
ATORVASTATIN (68)
ROSUVASTATIN (53)
ASPIRIN DL-LYSINE (30)
SEMAGLUTIDE (29)
NATALIZUMAB (23)
ASPIRIN (22)
DULAGLUTIDE (22)
SIMVASTATIN (18)
RIVAROXABAN (17)
CABOTEGRAVIR (14)